Athan Kuliopulos

8.3k total citations · 1 hit paper
94 papers, 6.6k citations indexed

About

Athan Kuliopulos is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Athan Kuliopulos has authored 94 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 33 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Athan Kuliopulos's work include Blood Coagulation and Thrombosis Mechanisms (37 papers), Protease and Inhibitor Mechanisms (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers). Athan Kuliopulos is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (37 papers), Protease and Inhibitor Mechanisms (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers). Athan Kuliopulos collaborates with scholars based in United States, United Kingdom and Canada. Athan Kuliopulos's co-authors include Lidija Covic, Anika Agarwal, Andrew J. Leger, Suzanne L. Jacques, Nicole C. Kaneider, Adrienne Boire, Amy L. Gresser, Katie O’Callaghan, Paul Talalay and Albert S. Mildvan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Athan Kuliopulos

94 papers receiving 6.5k citations

Hit Papers

PAR1 Is a Matrix Metallop... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athan Kuliopulos United States 48 2.9k 2.5k 1.3k 1.0k 957 94 6.6k
Whyte G. Owen United States 42 1.8k 0.6× 3.6k 1.4× 1.0k 0.8× 1.1k 1.1× 769 0.8× 128 6.6k
Claudia K. Derian United States 39 1.6k 0.5× 2.2k 0.9× 756 0.6× 630 0.6× 1.2k 1.3× 63 4.6k
Johan Stenflo Sweden 48 2.5k 0.9× 4.2k 1.7× 763 0.6× 550 0.5× 1.6k 1.6× 144 8.0k
Robert M. Scarborough United States 38 2.3k 0.8× 1.7k 0.7× 339 0.3× 2.3k 2.3× 506 0.5× 96 6.4k
Aviv Gazit Israel 45 5.3k 1.8× 1.0k 0.4× 913 0.7× 253 0.3× 920 1.0× 99 9.7k
Thomas O. Daniel United States 38 4.6k 1.6× 1.0k 0.4× 758 0.6× 181 0.2× 349 0.4× 58 7.2k
David C. Seldin United States 69 9.8k 3.4× 1.7k 0.7× 961 0.7× 421 0.4× 2.0k 2.0× 202 12.5k
Henrik Daub Germany 35 5.4k 1.9× 488 0.2× 524 0.4× 277 0.3× 462 0.5× 56 7.6k
François Marceau Canada 43 2.8k 1.0× 1.8k 0.7× 262 0.2× 880 0.9× 5.2k 5.4× 203 8.4k
Hisao Kato Japan 34 1.9k 0.7× 1.4k 0.5× 384 0.3× 371 0.4× 1.2k 1.3× 135 4.6k

Countries citing papers authored by Athan Kuliopulos

Since Specialization
Citations

This map shows the geographic impact of Athan Kuliopulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athan Kuliopulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athan Kuliopulos more than expected).

Fields of papers citing papers by Athan Kuliopulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athan Kuliopulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athan Kuliopulos. The network helps show where Athan Kuliopulos may publish in the future.

Co-authorship network of co-authors of Athan Kuliopulos

This figure shows the co-authorship network connecting the top 25 collaborators of Athan Kuliopulos. A scholar is included among the top collaborators of Athan Kuliopulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athan Kuliopulos. Athan Kuliopulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuliopulos, Athan, Paul A. Gurbel, Jeffrey J. Rade, et al.. (2020). PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization. Arteriosclerosis Thrombosis and Vascular Biology. 40(12). 2990–3003. 21 indexed citations
2.
Nguyen, Nga, et al.. (2020). Lipid Receptor GPR31 (G-Protein–Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis. Arteriosclerosis Thrombosis and Vascular Biology. 41(1). e33–e45. 23 indexed citations
3.
Covic, Lidija, et al.. (2019). Trace amine–associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells. Journal of Biological Chemistry. 294(12). 4401–4411. 35 indexed citations
4.
Kimmelstiel, Carey, Nga Nguyen, Ping Zhang, et al.. (2019). Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel. Thrombosis Research. 177. 59–69. 2 indexed citations
5.
Wieser, Verena, Timon E. Adolph, Barbara Enrich, et al.. (2016). Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors. Gut. 66(5). 930–938. 42 indexed citations
6.
Zhang, Ping, Lidija Covic, & Athan Kuliopulos. (2015). Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics. Methods in molecular biology. 1324. 191–203. 27 indexed citations
7.
Foley, Caitlin & Athan Kuliopulos. (2014). Mouse Matrix Metalloprotease‐1a (Mmp1a) Gives New Insight Into MMP Function. Journal of Cellular Physiology. 229(12). 1875–1880. 26 indexed citations
8.
Kaimal, Rajani, Raid Aljumaily, Sarah L. Tressel, et al.. (2013). Selective Blockade of Matrix Metalloprotease-14 with a Monoclonal Antibody Abrogates Invasion, Angiogenesis, and Tumor Growth in Ovarian Cancer. Cancer Research. 73(8). 2457–2467. 48 indexed citations
9.
Foley, Caitlin, Miriam Fanjul‐Fernández, Andrew Bohm, et al.. (2013). Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis. Oncogene. 33(17). 2264–2272. 35 indexed citations
10.
Hatziapostolou, Maria, Γεώργιος Κούκος, Christos Polytarchou, et al.. (2011). Tumor Progression Locus 2 Mediates Signal-Induced Increases in Cytoplasmic Calcium and Cell Migration. Science Signaling. 4(187). ra55–ra55. 24 indexed citations
11.
12.
Swift, Steven M., Jian Xu, Vishal Trivedi, et al.. (2010). A Novel Protease-activated Receptor-1 Interactor, Bicaudal D1, Regulates G Protein Signaling and Internalization. Journal of Biological Chemistry. 285(15). 11402–11410. 20 indexed citations
13.
Yang, Eric, Adrienne Boire, Anika Agarwal, et al.. (2009). Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis. Cancer Research. 69(15). 6223–6231. 121 indexed citations
14.
Miller, Jacquelyn, Anika Agarwal, Lakshmi A. Devi, et al.. (2009). Insider access: pepducin symposium explores a new approach to GPCR modulation. Annals of the New York Academy of Sciences. 1180(s1). E1–12. 36 indexed citations
15.
Agarwal, Anika, Lidija Covic, Leila M. Sevigny, et al.. (2008). Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Molecular Cancer Therapeutics. 7(9). 2746–2757. 86 indexed citations
16.
Nguyen, Nga, Athan Kuliopulos, Roger A. Graham, & Lidija Covic. (2006). Tumor-Derived Cyr61(CCN1) Promotes Stromal Matrix Metalloproteinase-1 Production and Protease-Activated Receptor 1–Dependent Migration of Breast Cancer Cells. Cancer Research. 66(5). 2658–2665. 66 indexed citations
17.
Seeley, Stacy K., James Baleja, & Athan Kuliopulos. (1996). NMR studies of the ''on'' and ''off'' states of the human thrombin receptor. Blood. 88(10). 87–87. 1 indexed citations
18.
Lin, Xue, Athan Kuliopulos, Albert S. Mildvan, & Paul Talalay. (1991). Catalytic mechanism of an active-site mutant (D38N) of .DELTA.5-3-ketosteroid isomerase. Biochemistry. 30(20). 4991–4997. 36 indexed citations
19.
Kuliopulos, Athan, Paul Talalay, & Albert S. Mildvan. (1990). Combined effects of two mutations of catalytic residues on the ketosteroid isomerase reaction. Biochemistry. 29(44). 10271–10280. 51 indexed citations
20.
Kuliopulos, Athan, Edwin M. Westbrook, Paul Talalay, & Albert S. Mildvan. (1987). Positioning of a spin-labeled substrate analog into the structure of .DELTA.5-3-ketosteroid isomerase by combined kinetic, magnetic resonance, and x-ray diffraction methods. Biochemistry. 26(13). 3927–3937. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026